XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 63 filers reported holding XENON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,497,000 | -67.5% | 396,589 | -71.8% | 0.41% | -68.7% |
| Q2 2019 | $13,858,000 | -3.0% | 1,405,476 | 0.0% | 1.30% | -8.8% |
| Q1 2019 | $14,280,000 | +61.0% | 1,405,476 | 0.0% | 1.42% | +25.7% |
| Q4 2018 | $8,869,000 | -52.2% | 1,405,476 | 0.0% | 1.13% | -39.4% |
| Q3 2018 | $18,552,000 | – | 1,405,476 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 467,368 | $7,188,000 | 3.91% |
| Ghost Tree Capital, LLC | 700,000 | $10,766,000 | 2.40% |
| BVF INC/IL | 3,499,346 | $53,820,000 | 2.12% |
| DAFNA Capital Management LLC | 346,535 | $5,330,000 | 1.59% |
| Parkman Healthcare Partners LLC | 361,689 | $5,563,000 | 1.42% |
| KNOTT DAVID M | 200,000 | $3,076,000 | 1.39% |
| Soleus Capital Management, L.P. | 558,117 | $8,584,000 | 1.13% |
| Avoro Capital Advisors LLC | 2,800,000 | $43,064,000 | 0.74% |
| NEA Management Company, LLC | 992,107 | $15,259,000 | 0.40% |
| Orbimed Advisors | 2,497,917 | $38,418,000 | 0.34% |